Abiprubart

Drug identity checked against registry records

Also recorded as KPL-404

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study to Evaluate the Efficacy and Safety of Abiprubart in Participants With Sjögren's DiseaseNCT06531395KNSAPhase 2Terminated2025-03-06Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.